• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide.

作者信息

Stuplich Moritz, Hadizadeh Dariusch R, Kuchelmeister Klaus, Scorzin Jasmin, Filss Christian, Langen Karl-Josef, Schäfer Niklas, Mack Frederic, Schüller Heinrich, Simon Matthias, Glas Martin, Pietsch Torsten, Urbach Horst, Herrlinger Ulrich

机构信息

Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Sigmund-Freud-Strasse 25, Bonn, Germany.

出版信息

J Clin Oncol. 2012 Jul 20;30(21):e180-3. doi: 10.1200/JCO.2011.40.9565. Epub 2012 Jun 11.

DOI:10.1200/JCO.2011.40.9565
PMID:22689800
Abstract
摘要

相似文献

1
Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide.洛莫司汀与替莫唑胺治疗后胶质母细胞瘤出现延迟性和持续性假性进展
J Clin Oncol. 2012 Jul 20;30(21):e180-3. doi: 10.1200/JCO.2011.40.9565. Epub 2012 Jun 11.
2
Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma.新诊断胶质母细胞瘤采用放化疗后序贯剂量密集或节拍式替莫唑胺的随机II期试验
J Clin Oncol. 2009 Aug 10;27(23):3861-7. doi: 10.1200/JCO.2008.20.7944. Epub 2009 Jun 8.
3
Adjuvant temozolomide: how long and how much?辅助性替莫唑胺：疗程多久及剂量多少？
Expert Rev Anticancer Ther. 2008 May;8(5):663-5. doi: 10.1586/14737140.8.5.663.
4
Glioblastoma treated with concurrent radiation therapy and temozolomide chemotherapy: differentiation of true progression from pseudoprogression with quantitative dynamic contrast-enhanced MR imaging.胶质母细胞瘤行同期放化疗治疗：定量动态对比增强磁共振成像鉴别真性进展与假性进展。
Radiology. 2015 Mar;274(3):830-40. doi: 10.1148/radiol.14132632. Epub 2014 Oct 21.
5
Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma.胶质母细胞瘤患者同步使用替莫唑胺和放疗后的早期坏死。
J Neurooncol. 2007 Mar;82(1):81-3. doi: 10.1007/s11060-006-9241-y. Epub 2006 Aug 31.
6
Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03.洛莫司汀联合替莫唑胺化疗加放疗用于新诊断胶质母细胞瘤的II期试验：UKT-03
J Clin Oncol. 2006 Sep 20;24(27):4412-7. doi: 10.1200/JCO.2006.06.9104.
7
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.O-6-甲基鸟嘌呤-DNA甲基转移酶（MGMT）启动子甲基化状态可预测新诊断的胶质母细胞瘤患者同步放化疗后假性进展的发生率及预后。
J Clin Oncol. 2008 May 1;26(13):2192-7. doi: 10.1200/JCO.2007.14.8163.
8
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.NOA-04 间变性胶质瘤序贯放化疗（采用丙卡巴肼、洛莫司汀和长春新碱或替莫唑胺）的随机 III 期试验
J Clin Oncol. 2009 Dec 10;27(35):5874-80. doi: 10.1200/JCO.2009.23.6497. Epub 2009 Nov 9.
9
Population-based study of pseudoprogression after chemoradiotherapy in GBM.基于人群的胶质母细胞瘤放化疗后假性进展研究。
Can J Neurol Sci. 2009 Sep;36(5):617-22. doi: 10.1017/s0317167100008131.
10
Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.复发恶性胶质瘤连续剂量密集替莫唑胺的 II 期试验：RESCUE 研究。
J Clin Oncol. 2010 Apr 20;28(12):2051-7. doi: 10.1200/JCO.2009.26.5520. Epub 2010 Mar 22.

引用本文的文献

1
Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.CeTeG/NOA-09 试验中的未检测到的假性进展：来自进展后生存和 MRI 分析的提示。
J Neurooncol. 2023 Sep;164(3):607-616. doi: 10.1007/s11060-023-04444-x. Epub 2023 Sep 20.
2
MR-based follow-up after brachytherapy and proton beam therapy in uveal melanoma.磁共振随访在眼黑色素瘤近距离放疗和质子束放疗后的应用。
Neuroradiology. 2023 Aug;65(8):1271-1285. doi: 10.1007/s00234-023-03166-1. Epub 2023 May 30.
3
The Progression Related Gene Affects the Prognosis of Glioblastoma Patients.
进展相关基因影响胶质母细胞瘤患者的预后。
Brain Sci. 2022 Jun 11;12(6):767. doi: 10.3390/brainsci12060767.
4
The Utility of Conventional Amino Acid PET Radiotracers in the Evaluation of Glioma Recurrence also in Comparison with MRI.传统氨基酸PET放射性示踪剂在评估胶质瘤复发中的应用以及与MRI的比较。
Diagnostics (Basel). 2022 Mar 29;12(4):844. doi: 10.3390/diagnostics12040844.
5
A systematic review of amino acid PET in assessing treatment response to temozolomide in glioma.一项关于氨基酸正电子发射断层扫描（PET）评估胶质瘤对替莫唑胺治疗反应的系统评价。
Neurooncol Adv. 2022 Feb 13;4(1):vdac008. doi: 10.1093/noajnl/vdac008. eCollection 2022 Jan-Dec.
6
Targeting glioblastoma using a novel peptide specific to a deglycosylated isoform of brevican.使用一种针对 brevican 去糖基化异构体的新型肽靶向胶质母细胞瘤。
Adv Ther (Weinh). 2021 Apr;4(4). doi: 10.1002/adtp.202000244. Epub 2021 Jan 20.
7
Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group.正电子发射断层扫描成像对脑胶质瘤患者放疗计划和监测的贡献——PET/RANO 小组的报告。
Neuro Oncol. 2021 Jun 1;23(6):881-893. doi: 10.1093/neuonc/noab013.
8
Conventional and advanced imaging throughout the cycle of care of gliomas.在胶质瘤的整个治疗周期中的常规和先进成像技术。
Neurosurg Rev. 2021 Oct;44(5):2493-2509. doi: 10.1007/s10143-020-01448-3. Epub 2021 Jan 7.
9
A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma.基于机器学习评估IDH野生型胶质母细胞瘤患者静态和动态FET-PET检测假性进展的初步研究
Cancers (Basel). 2020 Oct 22;12(11):3080. doi: 10.3390/cancers12113080.
10
Contribution of Different Positron Emission Tomography Tracers in Glioma Management: Focus on Glioblastoma.不同正电子发射断层显像示踪剂在胶质瘤治疗中的作用：聚焦胶质母细胞瘤
Front Oncol. 2019 Nov 1;9:1134. doi: 10.3389/fonc.2019.01134. eCollection 2019.